Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on PLR
Total 0 results
Nothing found
Sponsors and Collaborators
Dermatologic Surgery Center of Washington LLC and Skin Cancer Treatment Center
Peijas Hospital
Advanced Reconstructive Surgery Alliance
Center for HIV/AIDS Vaccine Immunology
the Regional Direction of Clinical Research
Nuseed Americas Inc.
Hangzhou Neoantigen Therapeutics Co., Ltd.
Universidad de Chile (UChile, Chile)
Hoffmann-La Roche
Marealis AS
Stefano Rizza
London Metropolitan University
delta medical promotions ag
HMO Gesundheitsplan Basel, Switzerland
mHealth Impact Lab
WillowWood Global LLC
Pedro Rodrigues Genta
IRCCS San Raffaele Roma
Washington State Attorney General's Office
Gynea Laboratorios SA
View Full List
Medical Conditions
ERYTHROCYTOSIS
CHD - Coronary Heart Disease
Urosepsis
Cervical Spondylotic Myelopathy
Tonsil Disease
Amniotic Fluid Leakage
Hyperthyroid
Apgar; 0-3 at 1 Minute
Charcot-Marie-Tooth Disease Type 2U (Diagnosis)
Midgut Carcinoid Tumor
Non-Hodgkin's Lymphoma (NHL) or Hodgkin's Disease (HD) in 2nd or Greater Complete Remission, Partial Remission
Urinary System Stones
Varicocele Grade III
Pancreatic Carcinoma; Lipoprotein a; Overall Survival; Prognosis
PURPURA
Hermansky Pudlak Syndrome
Flatulence
Survivors of Childhood Cancer
Hyperhidrosis Primary Focal Axilla
Unrestricted Arm Movement
View Full List
Drug Interventions
Atorvastatin
BIC/FTC/TAF
Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF)
Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets
MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate (q1w regimen)
Active Comparator: TU2670 320mg
Amivantamab
Silymarin (Silybum marianum)
Basiliximab
Delamanid
Ibrutinib
RhGM-CSF
Simvastatin
Neridronate
Metronidazole
Yohimbine hydrochloride
Immediate-release nicotinamide (SAD)
Vincristine
Etoposide
Rituxumab
View Full List
CROs by country
Contract Research Organizations in Belarus
Contract Research Organizations in Burkina Faso
Contract Research Organizations in Congo, DR of
Contract Research Organizations in Cote d'Ivoire
Contract Research Organizations in Indonesia
Contract Research Organizations in Iran
Contract Research Organizations in Ireland
Contract Research Organizations in Montenegro
Contract Research Organizations in Tanzania
Contract Research Organizations in Uganda
Contract Research Organizations in United Kingdom
Contract Research Organizations in Venezuela
Contract Research Organizations in Vietnam
CRO list by country
CROs in Djibouti
SGS
All CROs in Djibouti
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe